Related Experiment Video

Updated: Jun 16, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Can a decisional algorithm be used in first-line treatment of advanced nonsmall cell lung cancer?

Cesare Gridelli

    Current Opinion in Oncology
    |February 12, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
    08:54

    Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

    Published on: May 20, 2020

    Related Experiment Videos

    Last Updated: Jun 16, 2026

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
    08:54

    Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

    Published on: May 20, 2020

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Correction: Maione et al. Amivantamab Plus Lazertinib and Platin-Based Chemotherapy Plus Osimertinib in EGFR-Mutant NSCLC: How to Choose Among Them and When Is Monotherapy with Osimertinib Still the Best Option? Curr. Oncol. 2026, 33, 54.

    Current oncology (Toronto, Ont.)·2026

    Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT.

    Lung cancer (Amsterdam, Netherlands)·2026

    Lorlatinib and Amivantamab: A Paradigm Shift in EGFR and ALK Positive NSCLC, with More Effective but More Toxic Treatments Requiring a Well-Structured Shared Decision Making.

    Oncology research·2026

    Critique of phase II agents for non-small cell lung cancer: what is our clinical need and which agents have potential?

    Expert opinion on investigational drugs·2026

    Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.

    Cancer treatment and research communications·2026

    Amivantamab Plus Lazertinib and Platin-Based Chemotherapy Plus Osimertinib in EGFR-Mutant NSCLC: How to Choose Among Them and When Is Monotherapy with Osimertinib Still the Best Option?

    Current oncology (Toronto, Ont.)·2026

    Paraneoplastic neurological syndromes: an update on incidence, antibody discovery, and testing.

    Current opinion in oncology·2026

    Implementing liquid biopsy in HR+/HER2- metastatic breast cancer: challenges and opportunities.

    Current opinion in oncology·2026

    Antibody-drug conjugates in breast cancer: the first-line and curative setting.

    Current opinion in oncology·2026

    Peripheral neuropathies associated with immunoglobulin M monoclonal gammopathies and low-grade B-cell lymphomas: diagnostic and therapeutic approach.

    Current opinion in oncology·2026

    The many facets of Kaposi sarcoma-associated herpesvirus/human herpes virus-8 multicentric Castleman disease: clinical spectrum, diagnostic innovations, and therapeutic management.

    Current opinion in oncology·2026

    Haemophagocytic lymphohistiocytosis: a life threatening complication of lymphoma.

    Current opinion in oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us